Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment of the day
    • mfine raises Rs 28.5...

    mfine raises Rs 28.5 crore from Prime Venture Partners, others

    Written by Ruby Khatun Khatun Published On 2018-05-18T10:00:16+05:30  |  Updated On 18 May 2018 10:00 AM IST
    mfine raises Rs 28.5 crore from Prime Venture Partners, others

    New Delhi: Health-tech company mfine said it has raised USD 4.2 million (Rs 28.5 crore) funding led by Prime Venture Partners.


    Existing investors Stellaris Venture Partners and Mayur Abhaya (CEO and MD of LifeCell) also participated in the series A round. Including the current round, the startup has raised over USD 6 million and has 50 employees in Bengaluru.


    "We will use the funds to expand our network of hospital partners, our team, and technology. Within the first five months of launch, our platform saw over 10,000 consultations and this year, we are aiming for more than one lakh consultations," mfine co-founder and CEO Prasad Kompalli said.


    He added that the company is also working towards expanding to cities like Pune, Delhi-Gurugram, Hyderabad, and Chennai this year, taking the number of hospital partners to 50-60.


    mfine was founded in February last year by Ashutosh Lawania (Myntra co-founder) and Prasad Kompalli, a former business head at Myntra. The services were launched in December with mfine partnering hospitals instead of aggregating individual doctors on the platform.


    Kompalli said mfine already has more than 15 hospitals in Bengaluru such as CloudNine, Aster, and Ovum on its platform, consulting with patients across nine specialties.


    "Our platform ensures that users get access to doctors and other integrated experiences as they would when visiting a hospital as and when they need," he said.


    mfine also plans to launch additional services like monitoring of vitals, collection of sample for lab tests and medicine delivery at home soon.


    "We see a huge opportunity to bring the much needed, tech-driven transformation in the USD 50 billion primary healthcare delivery. With our deeply tech-driven approach and working with reputed providers, we are effectively creating a 'cloud clinic' where quality healthcare can be accessed on demand from anywhere," Kompalli said.

    AsterCloudnineexisting investorsfundFund raisefund raisingLifeCellMayur AbhayaMfinePrasad KompalliPrime Venture PartnersRaisesSeries A fundingStellaris Venture Partners
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok